ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,718.57
      0.28%
      US Tech 100
      19,359.60
      0.20%
      Dow Jones
      42,124.65
      0.00%
      Brent Oil
      74.855
      1.52%
      Bitcoin
      63,567.95
      0.38%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. ACE Convergence Acquisition Corporation (ACEV) Quote

      ACE Convergence Acquisition Corporation

      ACE Convergence Acquisition Corporation (ACEV)

      NASDAQ
      9.78
      0.00
      (0.00%)
      Closed September 23 4:00PM
      Delayed by 15 minutes
      9.78
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      9.78
      Bid
      9.00
      Ask
      10.00
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      9.78
      Open
      -
      Last Trade
      Last Trade Time
      -
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      ACEV Latest News

      More News

      ACE Convergence Acquisition Corp. and Tempo Automation, Inc. Announce Closing of Business Combination; Tempo Automation Holdings, Inc. to Trade on Nasdaq Under Ticker Symbols "TMPO" and “TMPOW”

      SAN FRANCISCO, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Tempo Automation, Inc., a leading software-accelerated electronics manufacturer, today announced that it completed its business combination with...

      November 23 2022
      GlobeNewswire Inc.

      Tempo Automation Secures Up To $100M in Committed Equity Financing with White Lion Capital

      SAN FRANCISCO, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Tempo Automation (“Tempo”), a leading software-accelerated electronics manufacturer, and ACE Convergence Acquisition Corp. (“ACE”) a special...

      November 21 2022
      GlobeNewswire Inc.

      Achronix Appoints Mahesh Karanth as CFO

      Achronix Appoints Mahesh Karanth as CFO PR Newswire SANTA CLARA, Calif., Oct. 12, 2022 Will Help Drive the Next Phase of Business and Financial Growth for the FPGA and eFPGA Pure Play...

      October 12 2022
      PR Newswire (US)

      Tempo Automation Hosts Financial Analyst Day

      Tempo Automation, Inc. (“Tempo Automation”), a leading software-accelerated electronics manufacturer, held a financial analyst day on Wednesday, September 14, 2022. Tempo Automation presented on...

      September 20 2022
      Business Wire

      Tempo Automation, Inc. and ACE Convergence Acquisition Corp. Announce Effectiveness of Registration Statement, Date of ACE’s Extraordinary General Meeting to Approve Proposed Business Combination

      Extraordinary General Meeting Scheduled for May 5, 2022Shareholders of Record as of April 13, 2022, are Eligible to Vote at Extraordinary General Meeting SAN FRANCISCO, April 18, 2022 (GLOBE...

      April 18 2022
      GlobeNewswire Inc.

      Tempo Automation to Participate in the 34th Annual Roth Conference

      Tempo Automation (“Tempo”), a leading software-accelerated electronics manufacturer, today announced that Joy Weiss, Tempo’s Chief Executive Officer, and Ryan Benton, Tempo’s Chief Financial...

      March 10 2022
      Business Wire

      ACE Convergence Acquisition Corp. Reminds Shareholders to Vote in Favor of Extension Proposals

      ACE Convergence Acquisition Corp. (Nasdaq: ACEV) (“ACE” or the “Company”) encourages its shareholders to vote in favor of (i) the proposal to amend its Amended and Restated Memorandum and...

      January 20 2022
      Business Wire

      Tempo Automation, Inc. Secures $200 Million Convertible Note Financing Led by Oaktree

      Tempo Automation, (“Tempo” or the “Company”), a leading software-accelerated electronics manufacturer, and ACE Convergence Acquisition Corp. (“ACE”) (Nasdaq: ACEV), a special purpose acquisition...

      January 19 2022
      Business Wire

      ACE Convergence Acquisition Corp. and Tempo Automation, Inc. Announce Additional Funding to Trust

      ACE Convergence Acquisition Corp. (“ACE”) (Nasdaq: ACEV), a special purpose acquisition company focusing on industrial and enterprise IT, and Tempo Automation, (“Tempo”), a leading...

      January 14 2022
      Business Wire

      Tempo Automation to Present at the CJS Securities 22nd Annual New Ideas for the New Year Conference

      Tempo Automation, Inc. (“Tempo” or the “Company”), a leading software-accelerated electronics manufacturer, today announced that Joy Weiss, Tempo's Chief Executive Officer, and Ryan Benton, the...

      January 10 2022
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MSSMaison Solutions Inc
      $ 1.42
      (98.60%)
      		6.52M
      TRNRInteractive Strength Inc
      $ 0.4081
      (72.70%)
      		20.78M
      HSCSHeart Test Laboratories Inc
      $ 4.28
      (45.58%)
      		3.85M
      SLXNSilexion Therapeutics Corporation
      $ 1.10
      (42.82%)
      		5.6M
      GBNYGenerations Bancorp NY Inc
      $ 15.34
      (39.45%)
      		135.3k
      BIVIBioVie Inc
      $ 1.29
      (-53.93%)
      		173.64k
      GHSIGuardion Health Sciences Inc
      $ 5.61
      (-46.67%)
      		4.25k
      TOIIWOncology Institute Inc
      $ 0.014
      (-25.13%)
      		23k
      FRESFresh2 Group Ltd
      $ 1.48
      (-18.68%)
      		21.91k
      LNWLight and Wonder Inc
      $ 94.71
      (-15.95%)
      		3.24k
      MLGOMicroAlgo Inc
      $ 0.2475
      (24.75%)
      		37M
      TRNRInteractive Strength Inc
      $ 0.4092
      (73.17%)
      		20.8M
      MSSMaison Solutions Inc
      $ 1.42
      (98.60%)
      		6.52M
      SLXNSilexion Therapeutics Corporation
      $ 1.10
      (42.82%)
      		5.61M
      HSCSHeart Test Laboratories Inc
      $ 4.26
      (44.90%)
      		3.85M

      Discussion

      View Full Feed
      MADDSTACKER MADDSTACKER 4 minutes ago
      Great news :)
      VFF
      PRCubaDog PRCubaDog 4 minutes ago
      This is pumper boys way of saying he lied and hasn't bought a share in years. 🤣🤣🤣 BK IMMINENT!
      INNDD
      fuagf fuagf 4 minutes ago
      You're right, two good posts by you questioning OMOLIVE's position, the first here ..

      I don't understand what you are trying to prove.

      2) Gradual increase in the age of eligibility for full benefits to age 66 in 2009 and to age 67 in 2027. The earnings test will also b
      jackson73 jackson73 4 minutes ago
      SEEL .41 ww on news out
      RIGATONI RIGATONI 4 minutes ago
      $6.68 with a new high on news...


      Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

      https://finance.yahoo.com/news/capricor-therapeutics-ann
      CAPR
      JohnSmith4 JohnSmith4 4 minutes ago
      BAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHHAHAHAHAHAHAHAHAHAHHAHA
      TSOI
      subslover subslover 5 minutes ago
      I told that dog over 1 month ago to call a plumber. He got upset with at that statement so Roto-Rooter never showed
      MLGO
      2020trader 2020trader 5 minutes ago
      this truly a garbage stock
      CLNV
      DGJR DGJR 5 minutes ago
      Where does it show how many shares he sold and or transferred to others, show the proof.
      AABB
      Volcano Volcano 5 minutes ago
      Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced today, following recent meetings with the U.S. Food and Drug Administration (FDA), its intent to file a Biologics License Applicat
      CAPR
      mascale mascale 5 minutes ago
      The actual "Gold Standard" in electrical conductors is Copper.
      HIRU
      bigstocksnbonds bigstocksnbonds 6 minutes ago
      Oct 25 is great!!

      Congrats on ALL!!!!!!!
      cottonmather cottonmather 6 minutes ago
      Langley Outdoors. Polls suggest a Trump win. 11 minutes https://www.youtube.com/watch?v=rt85n0Zfmts
      TheKid5 TheKid5 6 minutes ago
      No funding. WV is dead. 1 year wasted. the future is bright
      CLNV
      toogoodfella toogoodfella 6 minutes ago
      RE:.. The distribution of about 1M or more maybe the final.

      —//——-//—-

      CORRECTION: “100M or more”
      LEHNQ
      2020trader 2020trader 6 minutes ago
      expecting lower today
      SINC
      Mufaso Mufaso 6 minutes ago
      One thing I need to correct is that the allegation Toexane is making about stocking. The SEC filing says

      ...including breaches of the maximum levels of buffer stock...

      The normal stocking problem you have with a distributor is that they don't have enough. In this
      RVNC
      jay_tee jay_tee 6 minutes ago
      Go retake PUMP 101
      RNVA
      2020trader 2020trader 6 minutes ago
      guaranteed
      SINC
      carolinatiger carolinatiger 6 minutes ago
      As I continue to say. But yet, you are here. Everyone knows why.
      IGPK
      TheKid5 TheKid5 7 minutes ago
      Great call! The future is bright! Funding any day now.
      CLNV
      RIGATONI RIGATONI 7 minutes ago
      First news in a long time...

      Do the dd while its still down here

      https://x.com/rigatoni33/status/1838551947172860017
      Volcano Volcano 7 minutes ago
      Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced today, following recent meetings with the U.S. Food and Drug Administration (FDA), its intent to file a Biologics License Applicat
      CAPR
      nagoya1 nagoya1 8 minutes ago
      Without being cheeky, I stuck that K suppository where it belongs.
      FNMA
      FNMA
      MartinLutherKing MartinLutherKing 8 minutes ago
      Last call ALL aboard FOXO NYSE Spaceship AI medical revelation
      FOXO

      Your Recent History

      NASDAQ
      ACEV
      ACE Convergence Acquisit...
      Delayed Upgrade Clock